A significant increase in beta-catenin concentrations was noted in the kidneys of the CIS-treated Gal-3 wild-type mice compared to Gal-3 wild-type sham control mice, indicating statistical significance (p < 0.01) (Figure 11B). Here, LGALS3 is linked to in situ carcinoma.